Top Markets
#1 Useless Coin Useless Coin +39.03%
#2 Merlin's Seal BTC Merlin's Seal BTC +37.96%
#3 0G 0G +36.39%
#4 StonkBroker StonkBroker +35.78%
#5 SAFEcoin SAFEcoin +29.23%
#6 Arbitrum Arbitrum +22.61%
#7 Zora Zora +20.61%
#8 Full Moon Full Moon +18.06%
#9 Notcoin Notcoin +18.04%
#10 Dogs Dogs +17.45%
Coin of the day
Useless Coin Useless Coin
Настройки
Язык
Pусский
Валюта
USD
Тема
Evommune, Inc. Evommune, Inc.

Evommune, Inc.

EVMN
Ранг среди акций #13820
Evommune, Inc. is a United States-based clinical-stage biotechnology company... Evommune, Inc. is a United States-based clinical-stage biotechnology company dedicated to advancing novel therapeutic solutions. Their primary focus lies in addressing the underlying mechanisms of chronic inflammatory diseases. Initial clinical development efforts are concentrated on conditions such as chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. The company's investigational portfolio features EVO756, which is being developed for the treatment of chronic spontaneous urticaria (CSU) and atopic dermatitis (AD), and EVO301, intended for atopic dermatitis (AD) and ulcerative colitis (UC). Established in 2020, Evommune operates from its headquarters in Palo Alto, California.
Цена акции
$12.63
Рыночная капитализация
$458.19M
Изменение (1 день)
-3.26%
Изменение (1 год)
-
Страна
US
Торговля Evommune, Inc. (EVMN)

Категория

Healthcare
История цены акций Evommune, Inc. (EVMN)
Наивысшая цена закрытия: $13.94 2026-08-01

Наименьшая цена закрытия: $19.25 2025-11-01
История цены акций Evommune, Inc. с 2025 по 2026
Годовая динамика цены акций
Год Результативность
2026 (TTM) 9.44%
2025 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $544.38 39.22%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 45.21%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.01 -13.08%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.80 476.17%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $749.90 5.87%
CH